Nephrology and urology devices are used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organs prolapse. Hemodialysis and peritoneal dialysis (PD) are used for dialysis of kidney in patients with kidney failure. Hemodialysis is the most commonly used method for kidney dialysis. However, the market for peritoneal dialysis has observed a significant growth in the last two decades with the introduction of intermittent peritoneal dialysis (IPD), automated peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD) procedures.
The global nephrology and urology devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global nephrology and urology devices market segmentation is based on device types (dialysis devices, urinary stone treatment, lithotripters, ureteral stents, incontinence and pelvic organ prolapse treatment, sacral neuromodulation, mesh and slings, urinary incontinence and pelvic organ prolapse treatment devices, benign prostatic hyperplasia devices, BPH catheterization ablation devices, prostatic stents, endoscopy devices).
The global nephrology and urology devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global nephrology and urology devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global nephrology and urology devices market and included in this report are Fresenius Medical Care, Baxter International Inc., Asahi Kasei Corp., B Braun Group, C. R. Bard Inc., Cook Group Inc., Dornier MedTech, Nikkiso Co. Ltd., NxStage Medical Inc., Nipro Corporation, Rockwell Medical Technologies, Inc. and Terumo Corporation.